Ketamine in the Treatment of Major Depressive Disorder

Brent Luu; Elizabeth Rice; Philippe Goldin

doi:10.1016/j.nurpra.2019.07.016

Ketamine in the Treatment of Major Depressive Disorder

Brent Luu, Elizabeth Rice, Philippe Goldin

Betty Irene Moore School of Nursing

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Major depressive disorder (MDD) is a prevalent and highly debilitating psychiatric condition that affects many young adults worldwide. This brief review summarizes the current available data about the use of ketamine as a treatment for MDD. We describe pharmacological mechanisms, dose considerations, drug interactions, side effects, and the relevancy of ketamine in the treatment of MDD.

Original language	English (US)
Pages (from-to)	228-231
Number of pages	4
Journal	Journal for Nurse Practitioners
Volume	16
Issue number	3
DOIs	https://doi.org/10.1016/j.nurpra.2019.07.016
State	Published - Mar 2020

Keywords

depression
ketamine
major depressive disorder (MDD)
mechanism of ketamine
psychiatric conditions
treatment of MDD

ASJC Scopus subject areas

Advanced and Specialized Nursing

Access to Document

10.1016/j.nurpra.2019.07.016

Fingerprint Dive into the research topics of 'Ketamine in the Treatment of Major Depressive Disorder'. Together they form a unique fingerprint.

Cite this

@article{4e1fc531a32342489b517782d0931ba1,

title = "Ketamine in the Treatment of Major Depressive Disorder",

abstract = "Major depressive disorder (MDD) is a prevalent and highly debilitating psychiatric condition that affects many young adults worldwide. This brief review summarizes the current available data about the use of ketamine as a treatment for MDD. We describe pharmacological mechanisms, dose considerations, drug interactions, side effects, and the relevancy of ketamine in the treatment of MDD.",

keywords = "depression, ketamine, major depressive disorder (MDD), mechanism of ketamine, psychiatric conditions, treatment of MDD",

author = "Brent Luu and Elizabeth Rice and Philippe Goldin",

year = "2020",

month = mar,

doi = "10.1016/j.nurpra.2019.07.016",

language = "English (US)",

volume = "16",

pages = "228--231",

journal = "Journal for Nurse Practitioners",

issn = "1555-4155",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Ketamine in the Treatment of Major Depressive Disorder

AU - Luu, Brent

AU - Rice, Elizabeth

AU - Goldin, Philippe

PY - 2020/3

Y1 - 2020/3

N2 - Major depressive disorder (MDD) is a prevalent and highly debilitating psychiatric condition that affects many young adults worldwide. This brief review summarizes the current available data about the use of ketamine as a treatment for MDD. We describe pharmacological mechanisms, dose considerations, drug interactions, side effects, and the relevancy of ketamine in the treatment of MDD.

AB - Major depressive disorder (MDD) is a prevalent and highly debilitating psychiatric condition that affects many young adults worldwide. This brief review summarizes the current available data about the use of ketamine as a treatment for MDD. We describe pharmacological mechanisms, dose considerations, drug interactions, side effects, and the relevancy of ketamine in the treatment of MDD.

KW - depression

KW - ketamine

KW - major depressive disorder (MDD)

KW - mechanism of ketamine

KW - psychiatric conditions

KW - treatment of MDD

UR - http://www.scopus.com/inward/record.url?scp=85071721108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071721108&partnerID=8YFLogxK

U2 - 10.1016/j.nurpra.2019.07.016

DO - 10.1016/j.nurpra.2019.07.016

M3 - Article

AN - SCOPUS:85071721108

VL - 16

SP - 228

EP - 231

JO - Journal for Nurse Practitioners

JF - Journal for Nurse Practitioners

SN - 1555-4155

IS - 3

ER -

Ketamine in the Treatment of Major Depressive Disorder

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this